Venova Medical, Inc. (Venova Medical), a privately held company developing a next generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access today announced the initial closing of a $30M Series B funding round. Catalyst Health Ventures and a leading medical device company co-led the financing, with participation from ShangBay Capital, Mirae Asset Capital, KOFA Healthcare, Cadence Healthcare Ventures, Aphelion Capital and other new and existing investors. The funding will be used to further develop the company's technology and conduct clinical studies in the U.S. to support FDA regulatory approval. Venova Medical also announced the appointment of Darshana Zaveri, Managing Partner at Catalyst Health Ventures, to the company's Board of Directors.
Shant Vartanian is the UCSF founder.